Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4817)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2022 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zeng ZM, Mo N, Zeng J, Ma FC, Jiang YF, Huang HS, Liao XW, Zhu GZ, Ma J, Peng T. Advances in postoperative adjuvant therapy for primary liver cancer. World J Gastrointest Oncol 2022; 14(9): 1604-1621 [PMID: 36187393 DOI: 10.4251/wjgo.v14.i9.1604] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i9/1604.htm |
| Number | Citing Articles |
| 1 |
Hui Shao, Jingyan Chen, Ali Li, Lili Ma, Yongzhi Tang, Huazhong Chen, Yongping Chen, Junyan Liu. Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway. Applied Biochemistry and Biotechnology 2023; 195(8): 5217 doi: 10.1007/s12010-023-04511-z
|
| 2 |
Yanyan Ye, Ying Wang, Haoqian Xu, Fengming Yi. Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02955-5
|
| 3 |
Rui Luo, Chongkai Fang, Chuyao Chen, Ying Zhang, Ruiwei Yao, Jinan Wang, Hanqian Shi, Kunliang Feng, Mingli Hu, Chong Zhong. Adjuvant therapy with Jianpi Huayu decoction improves overall and recurrence-free survival after hepatectomy for hepatocellular carcinoma: a retrospective propensity score-matching study. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1212116
|
| 4 |
Jeng-Shiun Du, Shih-Hsien Hsu, Shen-Nien Wang. The Current and Prospective Adjuvant Therapies for Hepatocellular Carcinoma. Cancers 2024; 16(7): 1422 doi: 10.3390/cancers16071422
|
| 5 |
Yichen Peng, Xia Wu, Yurong Zhang, Yue Yin, Xianglin Chen, Ding Zheng, Jing Wang. An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 2305 doi: 10.2147/JHC.S413996
|
| 6 |
Yi-Hao Yen, Fang-Ying Kuo, Hock-Liew Eng, Yueh-Wei Liu, Chee-Chien Yong, Wei-Feng Li, Chih-Chi Wang, Chih-Yun Lin, Tyng-Yuan Jang. Tumor necrosis as a predictor of early tumor recurrence after resection in patients with hepatoma. PLOS ONE 2023; 18(11): e0292144 doi: 10.1371/journal.pone.0292144
|
| 7 |
Bowen Men, Huzhe Cui, Zhezhu Han, Xiuying Jin, Qiang Xu, Yongmin Jin, Zhengri Piao, Songnan Zhang. Evaluation of the efficacy of transarterial chemoembolization combined with microwave ablation followed by adjuvant therapy in patients with hepatocellular carcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1337396
|
| 8 |
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and management. Liver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004
|